Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 9553173)

Published in Eur J Nucl Med on April 01, 1998

Authors

T M Behr1, N Jenner, S Radetzky, M Béhe, S Gratz, S Yücekent, F Raue, W Becker

Author Affiliations

1: Department of Nuclear Medicine, Georg-August-University, Göttingen, Germany.

Articles citing this

Regulatory peptide receptors in human hepatocellular carcinomas. Gut (1999) 1.22

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol (1999) 1.15

Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours. Eur J Nucl Med Mol Imaging (2008) 1.07

Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy. J Nucl Med (2007) 1.01

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002. Eur J Nucl Med Mol Imaging (2003) 0.95

Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607. Eur J Nucl Med Mol Imaging (2011) 0.95

Radiolabelled peptides for oncological diagnosis. Eur J Nucl Med Mol Imaging (2012) 0.93

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives. Eur J Nucl Med Mol Imaging (2003) 0.90

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors. Amino Acids (2010) 0.90

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours. Eur J Nucl Med Mol Imaging (2007) 0.82

Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. Int J Nanomedicine (2012) 0.81

EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma. Front Oncol (2015) 0.80

Expression and cell-specific localization of cholecystokinin receptors in rat lung. World J Gastroenterol (2003) 0.78

Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties. EJNMMI Res (2013) 0.77

Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats. World J Gastroenterol (2005) 0.76

Evaluation of CCK2 receptor binding ligands: the inheritance of Thomas Behr. Eur J Nucl Med Mol Imaging (2011) 0.76

Nuclear medicine imaging and therapy of neuroendocrine tumours. Cancer Imaging (2006) 0.75

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms. Pharmaceuticals (Basel) (2017) 0.75

Synthesis and biological evaluation of a novel pentagastrin-toxin conjugate designed for a targeted prodrug mono-therapy of cancer. Int J Mol Sci (2008) 0.75

Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget (2016) 0.75

Articles by these authors

Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA (1996) 3.27

Cloning of a novel family of mammalian GTP-binding proteins (RagA, RagBs, RagB1) with remote similarity to the Ras-related GTPases. J Biol Chem (1995) 2.41

The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem J (2001) 2.36

The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21

The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J (2001) 2.16

The identification of leaf thionin as one of the main jasmonate-induced proteins of barley (Hordeum vulgare). Plant Mol Biol (1992) 2.08

An analysis of the saccadic system by means of double step stimuli. Vision Res (1979) 2.07

Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem (2000) 2.05

Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem (1996) 2.00

Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet (1985) 1.96

Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid (2000) 1.95

Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis. Eur Radiol (2002) 1.76

Prediction in the oculomotor system: smooth pursuit during transient disappearance of a visual target. Exp Brain Res (1985) 1.66

Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J (2001) 1.61

Towards metabolic mapping of the human retina. Microsc Res Tech (2007) 1.55

Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Cancer Res (1999) 1.51

Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int (2000) 1.46

Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr (1999) 1.45

Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) (1995) 1.44

Methyl mercury and inorganic mercury in Swedish pregnant women and in cord blood: influence of fish consumption. Environ Health Perspect (2003) 1.43

Further properties of the human saccadic system: eye movements and correction saccades with and without visual fixation points. Vision Res (1969) 1.43

Serum concentrations of organochlorines in men: a search for markers of exposure. Sci Total Environ (2000) 1.40

Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes (1998) 1.40

Influences on food choice perceived to be important by nationally-representative samples of adults in the European Union. Eur J Clin Nutr (1997) 1.39

[On the temporal disintegration of mono- and binaural intensity differences (sounds and white background noise)]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1967) 1.38

[Neonatal hyperthyroidism in non-diagnosed Basedow's disease of the mother. Problems of diagnosis and therapy illustrated by a case history]. Dtsch Med Wochenschr (1994) 1.37

Dietary intake estimations of organohalogen contaminants (dioxins, PCB, PBDE and chlorinated pesticides, e.g. DDT) based on Swedish market basket data. Food Chem Toxicol (2006) 1.35

Determination of antisera titres ing the single radial immunodiffusion method. Immunochemistry (1969) 1.35

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med (1998) 1.34

Estimating the distribution of usual dietary intake by short-term measurements. Eur J Clin Nutr (2002) 1.32

Natural and drug-induced variations of velocity and duration of human saccadic eye movements: evidence for a control of the neural pulse generator by local feedback. Biol Cybern (1981) 1.31

A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner (1990) 1.30

The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch Intern Med (1992) 1.29

Breast thermography after four years and 10000 studies. Am J Roentgenol Radium Ther Nucl Med (1972) 1.27

A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE) Eur J Nucl Med (1998) 1.25

The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J Neural Transm Suppl (2003) 1.25

JIP60, a methyl jasmonate-induced ribosome-inactivating protein involved in plant stress reactions. Proc Natl Acad Sci U S A (1994) 1.24

Human perception of horizontal trunk and head rotation in space during vestibular and neck stimulation. Exp Brain Res (1991) 1.21

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer (2001) 1.20

Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med (2000) 1.20

Cloning of two novel ADP-ribosylation factor-like proteins and characterization of their differential expression in 3T3-L1 cells. J Biol Chem (1994) 1.19

Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: suggested methods. International Society of Radiolabelled Blood Elements (ISORBE). Eur J Nucl Med (1999) 1.18

Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry (2004) 1.18

A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab (1998) 1.16

A European food consumption survey method--conclusions and recommendations. Eur J Clin Nutr (2002) 1.15

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J Nucl Med (1999) 1.13

European Nutrition and Health Report 2009. Ann Nutr Metab (2009) 1.13

Serious complications after radiosynoviorthesis. Survey on frequency and treatment modalities. Nuklearmedizin (2006) 1.12

Comparison of nutrient intake data calculated on the basis of two different databases. Results and experiences from a Swedish-Finnish study. Eur J Clin Nutr (2003) 1.12

Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters. J Lipid Res (1999) 1.12

Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer (1995) 1.10

Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy (1999) 1.10

Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases. Biochem Biophys Res Commun (1999) 1.10

The control of eye movements in the saccadic system. Bibl Ophthalmol (1972) 1.08

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol (2006) 1.08

Vestibular-neck interaction and transformation of sensory coordinates. J Vestib Res (1997) 1.07

Feynman's path-integral approach for intense-laser-atom interactions. Science (2001) 1.07

[Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors]. Blut (1968) 1.07

Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis. J Rheumatol (1999) 1.04

Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene (1999) 1.03

[Electron microscopic study on synovial cysts]. Arch Orthop Unfallchir (1969) 1.03

18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging (2002) 1.02

Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology (1996) 1.02

[Methods for the quantitative determination of plasma proteins by immunoprecipitation]. Z Klin Chem Klin Biochem (1968) 1.00

Electrophysiologic properties of alcohol in man. J Electrocardiol (1978) 1.00

STAT3 is enriched in nuclear bodies. J Cell Sci (2003) 1.00

[Therapy of bone tumors. Results of a collective study of 527 cases]. Chirurg (1974) 0.99

Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer (2003) 0.99

Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol (1996) 0.99

Visual object localisation in space. Interaction of retinal, eye position, vestibular and neck proprioceptive information. Exp Brain Res (2001) 0.99

Estimation of self-turning in the dark: comparison between active and passive rotation. Exp Brain Res (1999) 0.98

Treatment of fenestration and dehiscence bone defects around oral implants using the guided tissue regeneration technique: a prospective multicenter study. Int J Oral Maxillofac Implants (1995) 0.98

The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4. Neuroscience (2008) 0.98

Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer (1993) 0.97

The MNB/DYRK1A protein kinase: genetic and biochemical properties. J Neural Transm Suppl (2003) 0.97

Accuracy of saccadic eye movements and maintenance of eccentric eye positions in the dark. Vision Res (1973) 0.97

Anterior cruciate ligament and intercondylar notch in the coronal oblique plane: anatomy complemented by magnetic resonance imaging in cruciate ligament-intact knees. Arthroscopy (1999) 0.96

Characterisation of the mouse diabetes susceptibilty locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Diabetologia (2002) 0.96

Premature hair graying: a probable coronary risk factor. Angiology (1978) 0.96

Periodontal treatment without maintenance. A retrospective study in 44 patients. J Periodontol (1984) 0.96

MR imaging of a parosteal lipoma. Clin Imaging (2001) 0.96

Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. J Cancer Res Clin Oncol (1990) 0.96

Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab (1993) 0.95

The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol (Copenh) (1975) 0.95

An anti-CD4 antibody for treatment of chronic inflammatory arthritis. Agents Actions Suppl (1991) 0.95

Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.95

Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid (1992) 0.95

Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Endocrinology (1997) 0.95

Alternative mRNA splicing of the novel GTPase Rab28 generates isoforms with different C-termini. Eur J Biochem (1996) 0.95

Evaluation of titanium implants placed into simulated extraction sockets: a study in dogs. Int J Oral Maxillofac Implants (1999) 0.95

Calcium carbonate modifications in the mineralized shell of the freshwater snail Biomphalaria glabrata. Chemistry (2000) 0.95